~~<i id='78643B9149'><strike id='78643B9149'><tt id='78643B9149'><pre id='78643B9149'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：entertainment 2025-09-29 21:12:46 - browse：8579

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Illumina names Agilent executive as new CEO

Wikipedia

explore

knowledge

explore

focus

entertainment

AdobeTheUniversityofPennsylvania’sDivisionofRenal-ElectrolyteandHypertensionrecentlymadeaquietupdate

WSS

Canadians with cystic fibrosis outlive Americans by a decade

Covid hospitalizations on the rise, Humana says

How to fix cancer clinical trials' diversity problem

'Screen and refer' systems are hurting patients

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

A new House health package & hospitals’ new site

hotspot

Wikipedia

Wikipedia

At least 13 dead in Texas as scorching temps continue

Snackable artificial intelligence, expert AI, and the pharma industry

What does generative AI mean for health care? We asked experts

House transparency, PBM reform bill gains bipartisan support

Novavax promises a turnaround & Lilly roils the obesity market

Prescription digital therapeutics are key to pharma’s future

Continuity nursing helped my family in our darkest PICU moments

Skip the lead apron during X

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to fix cancer clinical trials' diversity problem

explore

Security flaws in third

Undocumented workers face uncertainty as immigration law takes effect in Florida

Dexcom's push to bring CGM to type 2 diabetes patients

Why Novartis is changing the name of its research labs

Crinetics acromegaly drug succeeds in late

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

knowledge

explore

focus

entertainment